Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial

Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with perennial allergic rhinitis (PAR) were investigated in a 52-week open-label study (JapicCTI-152952, clinicaltrials.jp). Methods: The rupatadine dose was fixed to 10 mg once daily for the first 2 weeks. The...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Drug Assess
Egile Nagusiak: Okubo, Kimihiro, Suzuki, Takamasa, Tanaka, Ayaka, Aoki, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2019
Gaiak:
Allergy & Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567265/
https://ncbi.nlm.nih.gov/pubmed/31231589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1614005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak